Found: 76
Select item for more details and to access through your institution.
Associations of the 2018 World Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR) cancer prevention recommendations with stages of colorectal carcinogenesis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14806, doi. 10.1002/cam4.6119
- By:
- Publication type:
- Article
LncRNA HClnc1 facilitates hepatocellular carcinoma progression by regulating PKM2 signaling and indicates poor survival outcome after hepatectomy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14526, doi. 10.1002/cam4.6117
- By:
- Publication type:
- Article
MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14511, doi. 10.1002/cam4.6116
- By:
- Publication type:
- Article
Nomograms for intraoperative prediction of lymph node metastasis in clinical stage IA lung adenocarcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14360, doi. 10.1002/cam4.6115
- By:
- Publication type:
- Article
Personalized circulating tumor DNA detection to monitor immunotherapy efficacy and predict outcome in locally advanced or metastatic non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14317, doi. 10.1002/cam4.6108
- By:
- Publication type:
- Article
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14337, doi. 10.1002/cam4.6111
- By:
- Publication type:
- Article
Impact of the pretreatment prognostic nutritional index on the survival after first‐line immunotherapy in non‐small‐cell lung cancer patients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14327, doi. 10.1002/cam4.6110
- By:
- Publication type:
- Article
Diagnostic value of high‐risk HPV other than type 16/18 in high‐grade cervical neoplasia among cytology‐negative women: A multicenter retrospective study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14794, doi. 10.1002/cam4.6109
- By:
- Publication type:
- Article
Clinical characteristics and outcomes for children, adolescents and young adults with "CIC‐fused" or "BCOR‐rearranged" soft tissue sarcomas: A multi‐institutional European retrospective analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14346, doi. 10.1002/cam4.6113
- By:
- Publication type:
- Article
Association between papillary thyroid carcinoma and cervical lymph node metastasis based on ultrasonic radio frequency signals.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14305, doi. 10.1002/cam4.6107
- By:
- Publication type:
- Article
A strategy to reduce the false‐positive rate after low‐dose computed tomography in lung cancer screening: A multicenter prospective cohort study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14781, doi. 10.1002/cam4.6106
- By:
- Publication type:
- Article
Who, where, when: Colorectal cancer disparities by race and ethnicity, subsite, and stage.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14767, doi. 10.1002/cam4.6105
- By:
- Publication type:
- Article
The prognostic role of cigarette smoking in Kidney Cancer Survival.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14756, doi. 10.1002/cam4.6104
- By:
- Publication type:
- Article
Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14293, doi. 10.1002/cam4.6103
- By:
- Publication type:
- Article
Insights into the leveraging of GABAergic signaling in cancer therapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14498, doi. 10.1002/cam4.6102
- By:
- Publication type:
- Article
Immunotherapy or antiangiogenic therapy plus chemotherapy as first‐line treatment of patients with PD‐L1(‐) advanced non‐squamous non‐small cell lung cancer in a Chinese cohort.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14282, doi. 10.1002/cam4.6101
- By:
- Publication type:
- Article
Treatment patterns and cost estimations of systemic chemotherapy for pancreatic cancer in Japan: A retrospective database study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14742, doi. 10.1002/cam4.6100
- By:
- Publication type:
- Article
The role of extracellular vesicles in the development of nasopharyngeal carcinoma and potential clinical applications.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14484, doi. 10.1002/cam4.6099
- By:
- Publication type:
- Article
Comparison of eight modern preoperative scoring systems for survival prediction in patients with extremity metastasis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14264, doi. 10.1002/cam4.6097
- By:
- Publication type:
- Article
Adherence and contamination in a 1‐year physical activity program in childhood cancer survivors: A report from the SURfit study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14731, doi. 10.1002/cam4.6096
- By:
- Publication type:
- Article
Potential noninvasive biomarkers for the malignant transformation of oral leukoplakia: A systematic review and meta‐analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14718, doi. 10.1002/cam4.6095
- By:
- Publication type:
- Article
The effect of propofol on chemosensitivity of paclitaxel in cervical cancer cells.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14403, doi. 10.1002/cam4.6064
- By:
- Publication type:
- Article
PIK3R3 is upregulated in liver cancer and activates Akt signaling to control cancer growth by regulation of CDKN1C and SMC1A.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14413, doi. 10.1002/cam4.6068
- By:
- Publication type:
- Article
Characteristics and clinical outcomes in young‐onset cholangiocarcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14094, doi. 10.1002/cam4.6063
- By:
- Publication type:
- Article
Using immunohistochemistry to classify the molecular subtypes of Paget's disease of the breast.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14104, doi. 10.1002/cam4.6066
- By:
- Publication type:
- Article
The role of area‐level socioeconomic disadvantage in racial disparities in cancer incidence in metropolitan Detroit.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14623, doi. 10.1002/cam4.6065
- By:
- Publication type:
- Article
Effect of electronic health (eHealth) on quality of life in women with breast cancer: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14252, doi. 10.1002/cam4.6094
- By:
- Publication type:
- Article
Cancer care patterns in South Korea: Types of hospital where patients receive care and outcomes using national health insurance claims data.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14707, doi. 10.1002/cam4.6093
- By:
- Publication type:
- Article
Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14694, doi. 10.1002/cam4.6091
- By:
- Publication type:
- Article
Disparities in cancer care among sexual and gender minority adolescent and young adult patients: A scoping review.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14674, doi. 10.1002/cam4.6090
- By:
- Publication type:
- Article
Efficacy of fusion imaging for immediate post‐ablation assessment of malignant liver neoplasms: A systematic review.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14225, doi. 10.1002/cam4.6089
- By:
- Publication type:
- Article
Prognostic nutritional index combined with NLR to construct a survival prediction model and decision analysis of patients with muscle‐invasive bladder cancer after surgery.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14207, doi. 10.1002/cam4.6088
- By:
- Publication type:
- Article
Adipose tissue area is a predictive biomarker for the efficacy of pegylated liposomal doxorubicin in platinum‐refractory/resistant ovarian cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14196, doi. 10.1002/cam4.6086
- By:
- Publication type:
- Article
Molecular and phenotypic characteristics influencing the degree of cytoreduction in high‐grade serous ovarian carcinomas.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14183, doi. 10.1002/cam4.6085
- By:
- Publication type:
- Article
Clinical characteristics and prognostic analysis of SMARCA4‐deficient non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14171, doi. 10.1002/cam4.6083
- By:
- Publication type:
- Article
Patient‐reported quality of life in adolescents and young adults with cancer who received radiation therapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14157, doi. 10.1002/cam4.6082
- By:
- Publication type:
- Article
Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14149, doi. 10.1002/cam4.6081
- By:
- Publication type:
- Article
Plasma lipid levels are associated with the CD8+ T‐cell infiltration and prognosis of patients with pancreatic cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14138, doi. 10.1002/cam4.6080
- By:
- Publication type:
- Article
A multicenter phase II trial of primary prophylactic PEG‐rhG‐CSF in pediatric patients with solid tumors and non‐Hodgkin lymphoma after chemotherapy: An interim analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14130, doi. 10.1002/cam4.6079
- By:
- Publication type:
- Article
Downregulation of miR‐100‐5p in cancer‐associated fibroblast‐derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14468, doi. 10.1002/cam4.6078
- By:
- Publication type:
- Article
Proteomic analysis identifies HMGA2 as a novel biomarker of overall survival in papillary renal cell carcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14851, doi. 10.1002/cam4.6077
- By:
- Publication type:
- Article
A preoperative nomogram model for the prediction of lymph node metastasis in buccal mucosa cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14120, doi. 10.1002/cam4.6076
- By:
- Publication type:
- Article
Development of cancer surveillance guidelines in ataxia telangiectasia: A Delphi‐based consensus survey of international experts.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14663, doi. 10.1002/cam4.6075
- By:
- Publication type:
- Article
Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial–mesenchymal transition by stabilizing YAP1.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14452, doi. 10.1002/cam4.6074
- By:
- Publication type:
- Article
Pan‐cancer analysis of oncogenic role of insulin‐like growth factor‐binding proteins and validation in ovarian cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14833, doi. 10.1002/cam4.6073
- By:
- Publication type:
- Article
LncRNA BCLET variant confers bladder cancer susceptibility through alternative splicing of MSANTD2 exon 1.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14440, doi. 10.1002/cam4.6072
- By:
- Publication type:
- Article
Insulin‐like growth factor binding protein‐2 and glucose‐regulated protein 78 kDa: Potential biomarkers affect prognosis in IDH‐wildtype glioblastoma patients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14426, doi. 10.1002/cam4.6071
- By:
- Publication type:
- Article
Multiple primary malignancies in 788 Chinese patients with diffuse large B‐cell lymphoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14112, doi. 10.1002/cam4.6070
- By:
- Publication type:
- Article
Factors of emotional distress in lymphoma: A systematic review.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14646, doi. 10.1002/cam4.6069
- By:
- Publication type:
- Article
Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19‐9, gender, and age.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 13, p. 14636, doi. 10.1002/cam4.6067
- By:
- Publication type:
- Article